Olanzapin Sandoz (Olanzapine)

Olanzapine, the active ingredient in Olanzapin Sandoz, is an atypical antipsychotic presented as a tablet for oral use. It treats schizophrenia and bipolar I disorder in adults and adolescents.

GNH USA supplies Olanzapin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olanzapin Sandoz is an atypical antipsychotic that modulates neurotransmission in several psychiatric disorders. - Schizophrenia: reduces positive and negative symptoms and helps maintain stability. - Bipolar I disorder (manic phase): controls acute manic episodes and helps prevent recurrence. - Schizoaffective disorder: alleviates psychotic features and mood symptoms. - Psychotic depression: augments antidepressant therapy by reducing psychotic symptoms.

Common Side Effects: - Weight gain: increased appetite and caloric intake. - Sedation: drowsiness or feeling of being slowed. - Dry mouth: reduced salivation. - Constipation: slowed gastrointestinal motility. - Elevated triglycerides: changes in lipid metabolism. - Blurred vision: transient visual disturbances.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: fever, rigidity, autonomic instability. - Tardive dyskinesia: involuntary, repetitive movements. - Hyperglycaemia/diabetes mellitus onset: significant rise in blood glucose. - Seizures: increased risk of convulsive episodes. - Agranulocytosis: marked reduction in white‑blood‑cell count. - Severe orthostatic hypotension: marked drop in blood pressure on standing.

When prescribing Olanzapin Sandoz, clinicians should consider several safety aspects. - Monitor metabolic parameters: weight, fasting glucose, lipid profile regularly. - Assess for movement disorders: watch for early signs of tardive dyskinesia. - Evaluate cardiovascular status: check blood pressure and heart rate periodically. - Review hepatic and renal function: dose adjustments may be needed in impairment. - Pregnancy and lactation: use only if benefits outweigh risks. - Store at below 25°C: keep in the original packaging, protect from moisture and light.

Olanzapin Sandoz can interact with various medicines, altering its efficacy or safety profile. Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase olanzapine plasma levels. - Strong CYP1A2 inducers: reduce olanzapine exposure. - CNS depressants: additive sedation and respiratory depression risk. Moderate Interactions (Monitor Closely): - Antihypertensive agents: may enhance hypotensive effects. - Anticholinergic drugs: increase anticholinergic burden. - Smoking: induces CYP1A2, potentially lowering olanzapine concentrations.